Earnings Per Share

3 Months Ended

Mar. 31, 2020

The following table presents net loss per share and related information:


	Three Months Ended March 31,						Years Ended December 31,
	2020		2019		2019		2018		2017
	(Unaudited)
	(in thousands, except for per share data)
Basic and diluted:
Net loss	$	(59,930)	$	(42,593)	$	(210,935)	$	(138,139)	$	(138,187)
Weighted average common shares outstanding	202,409,552.00		193,663,150.00		194,378,154		193,663,150		193,663,150
Basic and diluted net loss per share	$	(0.30)	$	(0.22)	$	(1.09)	$	(0.71)	$	(0.71)

Earnings per share calculations for all periods prior to the Virgin Galactic Business Combination have been retrospectively adjusted for the equivalent number of shares outstanding immediately after the Virgin Galactic Business Combination to effect the reverse recapitalization. Subsequent to the Virgin Galactic Business Combination, earnings per share will be calculated based on the weighted average number of common stock then outstanding.

Basic and dilutive net loss per share is computed by dividing the net loss for the period by the weighted average number of common stock outstanding during the period. The weighted average shares of common stock outstanding is based on the 193,663,150 shares of common stock outstanding immediately after the reverse recapitalization in connection with Virgin Galactic Business Combination and assumes these shares have been outstanding as of the beginning of the earliest period presented. The weighted average shares of common stock outstanding also reflects as of the closing date of the Virgin Galactic Business Combination the issuance of 1,924,402 shares to Boeing, the

issuance of 413,486 shares to settle transaction costs and the common stock equivalent of the vested 1,500,000 Director RSU Awards granted in connection to the Virgin Galactic Business Combination that remain unsettled as of March 31, 2020 and December 31, 2019.

For the three months ended March 31, 2020 and 2019 and December 31, 2019, the Company has excluded the potential effect of warrants to purchase shares of common stock totaling 10,419,699, 30,999,977 and 30,999,977 shares and the dilutive effect of outstanding stock options and unvested restricted stock units, as described in Note 13, in the calculation of diluted loss per share, as the effect would be anti-dilutive due to losses incurred.